GENE ONLINE|News &
Opinion
Blog

2026-04-17|

Researchers Use Superbase Ionic Liquids to Improve Curcumin Solubility and Anticancer Efficacy

by GOAI
Share To

Researchers have developed a novel method to enhance the solubility, bioavailability, and anticancer efficacy of curcumin using superbase ionic liquids (SILs), according to findings published on April 17, 2026. The study highlights the potential of SILs in addressing the long-standing challenge of curcumin’s poor water solubility, which has limited its therapeutic applications despite its known medicinal properties.

The research team employed superbase ionic liquids as a medium to dissolve curcumin more effectively. By doing so, they achieved significantly improved solubility compared to conventional methods. This advancement is particularly relevant for medical applications, as enhanced solubility directly correlates with increased bioavailability in biological systems. Furthermore, the study demonstrated that curcumin dissolved in SILs exhibited heightened anticancer activity during laboratory testing. These findings suggest that this approach could pave the way for more effective use of curcumin in cancer treatment and other therapeutic areas where its benefits have been hindered by formulation challenges.

 

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 17, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Contagious Yawning May Start in the Womb, Study in *Current Biology* Reveals
2026-05-10
New Medication Combinations Show Promise for Treatment-Resistant Depression in *JAMA Psychiatry* Study
2026-05-10
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
India’s Pharmaceutical Growth Slows: Industry Needs New Strategies
2026-05-10
Scroll to Top